Niva Bupa Health Insurance Company Ltd. share price target

Niva Bupa has been able to deliver standout growth in health insurance premiums (~40% CAGR between FY20–25 and 28% in Q1FY26 on a comparable basis (without 1/n).

We initiated coverage on Niva Bupa in Apr’25 highlighting the faster-thanindustry growth momentum, product innovation capabilities, high standards of customer servicing and its focus on strengthening profitability.

Niva Bupa posted a 20% YoY growth in NEP to INR12.2b (in line) in 1QFY26. The loss ratio at 77.9% (our est. of 72.3%) increased 1,390bp YoY due to the impact of 1/n, higher reserving led by suspension of auto adjudication of claims.

Niva Bupa Health Insurance (Niva) has emerged as one of the fastest-growing health insurers, delivering a CAGR of ~34% during FY22-25 and garnering the highest incremental market share in the retail health segment.

Niva Bupa has been able to deliver standout growth in health insurance premiums (~40% CAGR between FY20-25) while its improved scale and assets under management should help improve margins and earnings growth ahead (expect IFRS PAT CAGR of 53% over FY25-27E).

IPO Note - Niva Bupa Health Insurance Company Limited Issue Snapshot: Issue Open: November 07 November 11, 2024 Price Band: Rs. 70 74 *Issue Size: Up to Rs 2200 cr (Fresh issue of up to Rs 800 cr + Offer for sale of Up to Rs 1400 cr) Reservation for: QIB atleast 75% eq sh Non-Institutional upto 15% eq sh ((including 1/3rd for applications between Rs.2 lakhs to Rs.10 lakhs)) Retail upto 10% eq sh Face Value: Rs 10 Book value: Rs 11.95 (June 30, 2024) Bid size: - 200 equity shares and in multiples thereof 100% Book built Issue

IPO NOTE